Evolv Technologies Holdings, Inc. filings document the public-company disclosures of an AI-based security screening business with Class A common stock and warrants listed on Nasdaq. Its Form 8-K reports include financial-results releases, Regulation FD disclosures, board and officer changes, stockholder meeting results, credit-agreement disclosures and registration-statement amendments tied to resale securities and warrant exercises.
Proxy materials describe director elections, executive compensation, auditor ratification, board committee matters and shareholder voting procedures. The filings also identify capital-structure elements, including Class A common stock, warrants and subsidiary borrowing arrangements, alongside governance and reporting matters for Evolv’s screening technology operations.
At Evolv Technologies Holdings, Inc. (EVLV), director Neil Glat's unvested founder shares were automatically forfeited and cancelled on July 16, 2026: 17,500 shares and 15,091 shares, each for no consideration because applicable vesting conditions were not satisfied.
Evolv Technologies Holdings, Inc. (EVLV) director Kevin M. Charlton reported that 67,500 unvested founder shares were automatically forfeited and cancelled for no consideration on July 16, 2026, because applicable vesting conditions were not satisfied. Afterward, he held 291,510 Class A common shares directly and 44,081 shares indirectly through an IRA.
Evolv Technologies Holdings, Inc. (EVLV) received a Rule 144 notice from director David Mounts Gonzales covering a proposed sale of 50,000 shares of common stock through Merrill Lynch on Nasdaq. The notice also reports a prior sale of 50,000 shares in the past three months.
Evolv Technologies Holdings, Inc. (EVLV) director Richard A. Shapiro reported open-market purchases of a total of 32,600 shares of Class A Common Stock on September 4, 2026. He bought 13,500 shares directly at a weighted average price of $4.96 per share, increasing his direct holdings to 93,065 shares. Additional purchases were made through indirect accounts: 6,500 shares held by a trust over which he has voting and dispositive power (now 29,000 shares), 9,000 shares held by his spouse (now 39,000 shares), and 3,600 shares held in his spouse’s retirement plan (now 20,000 shares). No Rule 10b5-1 trading plan is reported.
Evolv Technologies Holdings, Inc. (EVLV) director Michael Ellenbogen reported an option exercise-and-sale transaction. On August 17, 2026 he exercised 80,752 stock options at an exercise price of $0.24 per share, acquiring an equal number of Class A common shares, then sold 80,752 shares of Class A common stock at a $5.59 weighted average price in open-market or private transactions. After the option exercise, he held 816,262 options directly, and an additional 151,135 shares are held indirectly through the Family Horizon Trust. The sales were effected under a Rule 10b5-1 trading plan entered into on June 12, 2025.
Evolv Technologies Holdings, Inc. (EVLV) received a notice under Rule 144 that director David Mounts Gonzales intends to sell restricted or control securities. The notice lists a proposed sale of 50,000 shares of common stock, with an aggregate market value of $282,543, to be sold through Merrill Lynch in open-market transactions on or about March 26, 2024, on Nasdaq.
Evolv Technologies Holdings, Inc. (EVLV) director Neil Glat purchased 8,500 shares of Class A Common Stock on August 14, 2026 at $5.74 per share in an open-market or private transaction. Following this transaction, he holds 252,100 shares with direct ownership.
Evolv Technologies Holdings, Inc. (EVLV) director Henrik Kuhl reported an open-market purchase of 15,000 shares of Class A Common Stock on 2026-08-14 at a weighted average price of $5.73 per share. These shares are held indirectly by a trust for which he is a co-trustee and beneficiary. Following the transactions reported, he also holds 9,291 shares directly.
Evolv Technologies Holdings, Inc. reported higher revenue and narrower losses for the three and six months ended June 30, 2026. Total revenue for the first half of 2026 was $90.1 million, up from $64.6 million, driven mainly by growth in subscription revenue to $47.9 million and product revenue to $22.5 million. Gross profit rose to $45.6 million, reflecting scale across product, subscription, and services.
Operating expenses for the first half were $64.6 million versus $67.3 million, with lower general and administrative costs and no 2025‑type restructuring charges, leading to a reduced loss from operations of $19.0 million. Net loss for the first half improved to $14.3 million from $42.2 million, or $0.08 per share versus $0.26. Operating activities generated $8.7 million of cash, compared with a small outflow a year earlier.
As of June 30, 2026, Evolv held $62.6 million in cash, cash equivalents and marketable securities, with $30.0 million of term debt outstanding and additional borrowing capacity under its $75.0 million Senior Secured Credit Facilities. Deferred revenue was $92.2 million and remaining performance obligations totaled $312.6 million, supporting future subscription visibility. The company remains in compliance with its ARR and liquidity covenants but continues to expect losses as it invests for growth and manages ongoing class‑action and derivative settlements and an SEC inquiry.
Evolv Technologies Holdings reported strong second-quarter 2026 results, with revenue of $43.8 million, up 34% year-over-year, and Annual Recurring Revenue of $132.7 million, up 20%. The company added 70 new customers and ended the quarter with Remaining Performance Obligation of $312.6 million.
Net loss narrowed to $(9.3) million, or $(0.05) per share, from $(40.5) million a year earlier, while Adjusted EBITDA improved to $4.4 million from $2.1 million, yielding a 10.1% Adjusted EBITDA margin. For the first six months of 2026, revenue was $90.1 million, up 40% year-over-year, with Adjusted EBITDA of $8.4 million.
The company ended June 30, 2026 with $63.4 million in cash, cash equivalents, marketable securities, and restricted cash, up $2.3 million sequentially, and generated $8.7 million of operating cash flow in the first half. Management raised 2026 guidance, now expecting total revenue of $180–$185 million and ending ARR of $148–$150 million, and targets Adjusted EBITDA of $15–$16 million with margins in the high single digits.